| Q87364388 | 5(th) Asian PAD Workshop |
| Q37978288 | A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. |
| Q37441011 | Albuminuria and peripheral arterial disease: results from the multi-ethnic study of atherosclerosis (MESA). |
| Q93022912 | Alprostadil treatment of critical limb ischemia in hemodialysis patients : A retrospective single-center analysis |
| Q37616714 | Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time? |
| Q38646310 | Ankle-brachial Index for the Prognosis of Cardiovascular Disease in Patients with Mild Renal Insufficiency |
| Q36197717 | Association of High-Density Lipoprotein Subclasses with Chronic Kidney Disease Progression, Atherosclerosis, and Klotho |
| Q37035402 | Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. |
| Q33562005 | Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). |
| Q89136000 | Association of hyperleptinemia with peripheral arterial disease in hypertensive patients |
| Q52957918 | Calcification score evaluation in patients listed for renal transplantation. |
| Q35223968 | Cardio-renal cachexia syndromes (CRCS): pathophysiological foundations of a vicious pathological circle |
| Q34572435 | Cardiorenal syndrome type 4-cardiovascular disease in patients with chronic kidney disease: epidemiology, pathogenesis, and management. |
| Q93145972 | Carotid Intima-Media Thickness: A Surrogate Marker for Cardiovascular Disease in Chronic Kidney Disease Patients |
| Q89682072 | Cholesterol-Lowering Action of a Novel Nutraceutical Combination in Uremic Rats: Insights into the Molecular Mechanism in a Hepatoma Cell Line |
| Q38111136 | Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention |
| Q90999572 | Chronic kidney disease exacerbates ischemic limb myopathy in mice via altered mitochondrial energetics |
| Q35116672 | Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study |
| Q35535488 | Cyclophilin A is associated with peripheral artery disease and chronic kidney disease in geriatrics: The Tianliao Old People (TOP) study |
| Q28534470 | Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? |
| Q40928437 | Diabetes, hyperglycemia, and the burden of functional disability among older adults in a community-based study |
| Q37763587 | Diabetic foot disease in people with advanced nephropathy and those on renal dialysis |
| Q36493454 | Diagnosis and management of peripheral artery disease in women |
| Q40385266 | Dietary intake and peripheral arterial disease incidence in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q38581284 | Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. |
| Q40199793 | Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis |
| Q89727361 | Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 |
| Q30238784 | Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association |
| Q55399715 | High Fibroblast Growth Factor 23 concentrations in experimental renal failure impair calcium handling in cardiomyocytes. |
| Q57178012 | High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q39125093 | Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. |
| Q38550979 | Influence of chronic kidney disease on cardiac structure and function |
| Q50502242 | Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. |
| Q37285963 | Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999-2002. |
| Q89486519 | Kidney function predicts the risk of asymptomatic peripheral arterial disease in a Chinese community-based population |
| Q46009914 | Kidney function, bone-mineral metabolism markers, and future risk of peripheral artery disease. |
| Q36454455 | Low ankle-brachial index and the development of rapid estimated GFR decline and CKD |
| Q35556264 | Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis |
| Q34675813 | MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC Study |
| Q38675005 | Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data |
| Q52629638 | Myeloperoxidase derived oxidants damage artery wall proteins in an animal model of chronic kidney disease accelerated atherosclerosis. |
| Q46404554 | Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis. |
| Q53667121 | Neointimal hyperplasia and calcification in medium sized arteries in adult patients with chronic kidney disease. |
| Q40217634 | Peripheral arterial disease preoperatively may predict graft failure and mortality in kidney transplant recipients |
| Q35621575 | Peripheral arterial disease, prevalence and cumulative risk factor profile analysis |
| Q34625055 | Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes |
| Q37883007 | Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis |
| Q35791729 | Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease |
| Q30656525 | Polymorphisms in genes encoding antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese - cross-sectional data from the J-MICC study |
| Q44174277 | Rate of ankle-brachial index decline predicts cardiovascular mortality in hemodialysis patients |
| Q44228580 | Relationship between kidney function and risk of asymptomatic peripheral arterial disease in elderly subjects |
| Q47669314 | Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease |
| Q36652294 | Risk factors for peripheral arterial disease among patients with chronic kidney disease |
| Q24633404 | Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study |
| Q40360879 | Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort |
| Q35176887 | Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients |
| Q34008968 | Serum metabolomic profiling and incident CKD among African Americans |
| Q34762649 | Subclinical atherosclerotic changes related to chronic kidney disease in asymptomatic black and white young adults: the Bogalusa heart study |
| Q46334556 | The Angio-Seal arterial closure device for early ambulation after elective percutaneous coronary intervention in patients receiving low-dose enoxaparin |
| Q39858468 | The Impact of Chronic Kidney Disease on Hospitalized Patients With Peripheral Arterial Disease and Critical Limb Ischemia |
| Q37566082 | The burden of peripheral artery disease and the role of antiplatelet therapy |
| Q30487191 | The link between chronic kidney disease and cardiovascular disease |
| Q37042178 | Timing of onset of CKD-related metabolic complications |
| Q37028901 | Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease |
| Q88648379 | Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study |
| Q34238435 | Warfarin dosing in patients with impaired kidney function |